88 related articles for article (PubMed ID: 20386017)
21. Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.
Matz M; Lehnert M; Lorkowski C; Fabritius K; Unterwalder N; Doueiri S; Weber UA; Mashreghi MF; Neumayer HH; Budde K
Transpl Int; 2012 Oct; 25(10):1106-16. PubMed ID: 22816666
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of JAK3 and PKC via Immunosuppressive Drugs Tofacitinib and Sotrastaurin Inhibits Proliferation of Human B Lymphocytes In Vitro.
Martina MN; Ramirez Bajo MJ; Bañon-Maneus E; Moya Rull D; Hierro-Garcia N; Revuelta I; Campistol JM; Rovira J; Diekmann F
Transplant Proc; 2016 Nov; 48(9):3046-3052. PubMed ID: 27932144
[TBL] [Abstract][Full Text] [Related]
23. The protein kinase C inhibitor sotrastaurin allows regulatory T cell function.
de Weerd A; Kho M; Kraaijeveld R; Zuiderwijk J; Weimar W; Baan C
Clin Exp Immunol; 2014 Feb; 175(2):296-304. PubMed ID: 24131367
[TBL] [Abstract][Full Text] [Related]
24. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
[TBL] [Abstract][Full Text] [Related]
25. Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.
Hebert MF; Blough DK; Townsend RW; Allison M; Buell D; Keirns J; Bekersky I
J Clin Pharmacol; 2005 Sep; 45(9):1018-24. PubMed ID: 16100295
[TBL] [Abstract][Full Text] [Related]
26. Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients.
Budde K; Sommerer C; Becker T; Asderakis A; Pietruck F; Grinyo JM; Rigotti P; Dantal J; Ng J; Barten MJ; Weber M
Am J Transplant; 2010 Mar; 10(3):571-81. PubMed ID: 20121745
[TBL] [Abstract][Full Text] [Related]
27. FTY720 and cyclosporine: evaluation for a pharmacokinetic interaction.
Kovarik JM; Schmouder RL; Barilla D; Büche M; Rouilly M; Berthier S; Wang Y; Van Saders C; Mayer T; Gottlieb AB
Ann Pharmacother; 2004; 38(7-8):1153-8. PubMed ID: 15138297
[TBL] [Abstract][Full Text] [Related]
28. Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.
Masuda S; Goto M; Fukatsu S; Uesugi M; Ogura Y; Oike F; Kiuchi T; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2006 Jan; 79(1):90-102. PubMed ID: 16413244
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
[TBL] [Abstract][Full Text] [Related]
30. Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection.
Zhang L; Qi Z; Wu D; Shan S; Ekberg H
Scand J Immunol; 2004 Mar; 59(3):255-60. PubMed ID: 15030575
[TBL] [Abstract][Full Text] [Related]
31. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S
Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266
[TBL] [Abstract][Full Text] [Related]
32. The novel immunosuppressive protein kinase C inhibitor sotrastaurin has no pro-viral effects on the replication cycle of hepatitis B or C virus.
von Hahn T; Schulze A; Chicano Wust I; Heidrich B; Becker T; Steinmann E; Helfritz FA; Rohrmann K; Urban S; Manns MP; Pietschmann T; Ciesek S
PLoS One; 2011; 6(9):e24142. PubMed ID: 21909416
[TBL] [Abstract][Full Text] [Related]
33. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M
Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
[TBL] [Abstract][Full Text] [Related]
34. Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients.
Min DI; Chen HY; Lee MK; Ashton K; Martin MF
Pharmacotherapy; 1997; 17(3):457-63. PubMed ID: 9165550
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results.
Russ GR; Tedesco-Silva H; Kuypers DR; Cohney S; Langer RM; Witzke O; Eris J; Sommerer C; von Zur-Mühlen B; Woodle ES; Gill J; Ng J; Klupp J; Chodoff L; Budde K
Am J Transplant; 2013 Jul; 13(7):1746-56. PubMed ID: 23668931
[TBL] [Abstract][Full Text] [Related]
36. Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction.
Takahashi HK; Iwagaki H; Yagi T; Kanke T; Liu K; Yoshino T; Tanaka N; Nishibori M
Clin Immunol; 2007 Jun; 123(3):324-32. PubMed ID: 17482516
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.
Blanchet B; Duvoux C; Costentin CE; Barrault C; Ghaleh B; Salvat A; Jouault H; Astier A; Tod M; Hulin A
Ther Drug Monit; 2008 Aug; 30(4):412-8. PubMed ID: 18641556
[TBL] [Abstract][Full Text] [Related]
38. Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis.
Vukmanovic-Stejic M; McQuaid A; Birch KE; Reed JR; Macgregor C; Rustin MH; Akbar AN
Br J Dermatol; 2005 Oct; 153(4):750-7. PubMed ID: 16181456
[TBL] [Abstract][Full Text] [Related]
39. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells.
Puzik A; Schultz C; Iblher P; Müller-Steinhardt M; Härtel C
Acta Paediatr; 2007 Oct; 96(10):1483-9. PubMed ID: 17880416
[TBL] [Abstract][Full Text] [Related]
40. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
Hess DA; Bird IA; Almawi WY; Rieder MJ
J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]